This is an automatically translated article.
Espanlir Inj is indicated in the treatment of disorders initiated in hepatic pre-coma, hepatic coma, hyperammonemic states in liver diseases such as acute and chronic hepatitis and cirrhosis,... Let's find out the necessary information about the drug Espanlir Inj through the article below.
1. What is Espanlir Inj?
Espanlir Inj has the following ingredients:
Active ingredient: L-ornithin-L-aspartat. Excipients: Potassium metabisulfite, water for injection. Drug group: Gastrointestinal drugs.
Dosage form: Solution for injection.
Packing: Box of 10 tubes of 5ml.
Manufacturer: Korea Prime Pharma - Korea.
2. Uses of Espanlir Inj
Indications of Espanlir Inj:
Treatment of acute or chronic liver diseases such as cirrhosis, hepatitis and fatty liver. Hepatic coma and hepatic pre-coma (hyperammonemia). Dosage and administration:
Acute or chronic hepatitis: The usual dose is 2 ampoules slow intravenous injection daily for 3 - 4 weeks. Hepatic coma, hepatic coma: Infusion should not exceed 40g/24 hours, depending on disease status. Maximum transmission speed 5g/hour. Do not exceed 30g/500mL of infusion. How to handle when missed dose, overdose of Espanlir Inj:
In case of forgetting dose of Espanlir Inj, it is advisable to supplement as soon as possible. However, if it is almost time for the next dose, skip the missed dose of Espanlir Inj and use a new dose. When using Espanlir Inj drug overdose, the patient should stop the drug immediately and go to the nearest medical facility for timely treatment.
3. Notes when using Espanlir Inj
Contraindications to Espanlir Inj in the following cases:
People with hypersensitivity to the ingredients of the drug. Severe renal impairment (serum creatinine > 3mg/100mL). Lactic acidosis, Methanol poisoning and Fructose - sorbitol intolerance. In addition, when using Espanlir Inj, patients should also note a number of issues such as:
In the case of high doses of the drug, it is necessary to check the concentration of urea in the blood and urine. When cutting the ampoule, care should be taken to avoid the risk of glass shards. Elderly and children need to be careful when using the drug. Inject Espanlir Inj slowly intravenously. Use caution when using Espanlir Inj with drugs containing potassium metabisulfite. Be aware of the risk of anaphylaxis when using intravenous drugs. If during the use of Espanlir Inj, there are unusual signs or symptoms that do not improve after 1 month, the patient should stop taking the drug and notify the doctor for timely treatment.
4. Side effects of the drug Espanlir Inj
At therapeutic doses, Espanlir Inj was well tolerated. However, the process of using Espanlir Inj, patients may still experience side effects such as:
Digestive disorders: Nausea, vomiting, flatulence, diarrhea, stomach pain and burning sensation in the bar manage. Very rare musculoskeletal and connective tissue disorders. If you experience these symptoms, the patient should stop using Espanlir Inj and notify the doctor for appropriate treatment.
Above is all information about the drug Espanlir Inj, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Espanlir Inj for home treatment because there may be unwanted side effects.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
